Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2000
09/19/2000US6121248 Anti-viral agent
09/19/2000US6121246 Method for treating ischemic tissue
09/19/2000US6121244 Antitumoral method by administration of partricin derivatives
09/19/2000US6121243 Prophylaxis of skin against ageing, against inflammation and for protection from photoreaction and oxidative influences
09/19/2000US6121242 Treatment of bacterial dysentery
09/19/2000US6121234 Use of essential oils to increase bioavailability of orally administered pharmaceutical compounds
09/19/2000US6121230 Administering polypeptide acting as vascular endothelial growth factor antagonist to treat and/or prevent endometriosis
09/19/2000US6121214 Making a liquid washing product comprising incorporating triclocarban in microencapsulated form into the liquid washing product
09/19/2000US6121047 Antisense modulation of SHP-1 expression
09/19/2000US6121046 Synthetic antisense oligodeoxynucleotides targeted to human ache
09/19/2000US6121036 Purified, host-specific, nontoxic, wide host range, virulent preparation against staphylococcus, helicobacter, mycobacterium, streptococcus, klebsiella, enterobacter, proteus, bacteriodes, pseudomonas, escherichia and others
09/19/2000US6121028 MurE
09/19/2000US6121010 Screening for compounds which reduce alcohol (ethanol) consumption by determining effectiveness for inhibiting aldehyde dehydrogenase activity on aldehydes derived from substrates of monoamine oxidase
09/19/2000US6121005 Human growth arrest specific homeobox protein; transcription factor; for treatment of postangioplasty restenosis and other cardiovascular disorders; for screening cellular partners
09/19/2000US6121000 Nucleotide sequences; antimetastatis agents; for inhibiting growth of chemotherapy resistant tumors and increasing sensitivity of tumors to chemotherapy
09/19/2000US6120995 Compositions that specifically bind to colorectal cancer cells and methods of using the same
09/19/2000US6120807 Prolonged release of GM-CSF
09/19/2000US6120806 Oral formulations for controlled release of alcohol deterrents
09/19/2000US6120804 Topical drug preparations
09/19/2000US6120803 Having segment of dosage form that is of sufficient rigidity to withstand contractions of stomach and delay expulsion of dosage form from stomach until substantially all of active agent has been dispensed
09/19/2000US6120802 Coextruding thermoplastic, pharmacologically acceptable polymeric binder which is soluble or swellable in physiological environment and pharmaceutical active ingredient; shaping coextruded material to required drug form
09/19/2000US6120800 Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties
09/19/2000US6120799 For treatment and diagnosisdiseases and abnormalities such as cancer, wound healing, and chronic inflammatory diseases
09/19/2000US6120798 Liposome-entrapped polynucleotide composition and method
09/19/2000US6120794 Emulsion and micellar formulations for the delivery of biologically active substances to cells
09/19/2000US6120793 Transdermal administering
09/19/2000US6120785 Antimycotic ectoparasiticidal product-external use
09/19/2000US6120779 Use of partial and complete salts of choline and carboxylic acids for the treatment of skin disorders
09/19/2000US6120777 High fluorescence specific immune enhancing factor and methods of use for same
09/19/2000US6120771 Isolated polypeptide; diagnosis, therapy
09/19/2000US6120766 CDW52-specific antibody for treatment of multiple sclerosis
09/19/2000US6120765 Purified peptide
09/19/2000US6120758 Preservative system for topically applied products
09/19/2000US6120756 Topical anionic salicylate for disorders of the skin
09/19/2000US6120752 Vial equipped with dispensing valve
09/19/2000US6119687 Partial liquid breathing of fluorocarbons
09/19/2000CA2273834A1 Immunomodulator, immunomodulator food and immunomodulator feed
09/19/2000CA2199294C Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
09/19/2000CA2184914C Isoxazoline compounds as 5-lipoxygenase inhibitors
09/19/2000CA2141679C New derivatives of neuraminic acid
09/19/2000CA2107484C New arylalkyl(thio)amides, their preparation process and pharmaceutical compositions containing them
09/19/2000CA2047550C Pharmaceutically useful anthracene compounds
09/19/2000CA2029420C Pharmaceutical compositions and methods for inhibition of maillard's reaction
09/19/2000CA2018563C N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments
09/15/2000CA2301679A1 Medication for treatment of functional distrubances or illnesses of the lower intestinal tract, particularly abdominal visceral pain which accompanies them
09/14/2000WO2000053776A2 Human kallikrein-like genes
09/14/2000WO2000053750A1 Compositions and methods for the treatment of tumors
09/14/2000WO2000053747A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl)
09/14/2000WO2000053745A1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same
09/14/2000WO2000053637A1 INCLUSION COMPLEXES OF POLYUNSATURATED FATTY ACIDS AND THEIR DERIVATIVES WITH η-CYCLODEXTRIN
09/14/2000WO2000053619A1 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
09/14/2000WO2000053618A1 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
09/14/2000WO2000053615A1 L-arabino-disaccharides of anthracyclines, processes for their preparation, and pharmaceutical compositions containing them
09/14/2000WO2000053614A1 Method for producing glyco-conjugates of 20(s)-camptothecin
09/14/2000WO2000053610A2 4-OXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS
09/14/2000WO2000053608A1 Pyridopyranoazepine derivatives, preparation and therapeutic use
09/14/2000WO2000053607A1 Camptothecin derivatives having antitumor activity
09/14/2000WO2000053606A1 Pyridoxal analogues for vitamin b-6 disorders
09/14/2000WO2000053605A1 Tyrosine kinase inhibitors
09/14/2000WO2000053604A1 Carbamoyl tetrahydropyridine derivatives
09/14/2000WO2000053603A1 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents
09/14/2000WO2000053602A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053600A1 Novel piperidine derivatives
09/14/2000WO2000053596A2 Imidazole compounds as histamine h3 ligands
09/14/2000WO2000053595A1 Pyrimidine compounds
09/14/2000WO2000053594A1 Aminomethylpyrrolidine derivatives having aromatic substituents
09/14/2000WO2000053592A1 Osteogenesis promoters
09/14/2000WO2000053591A1 Thiazolyl urea derivatives and their utilization as antiviral agents
09/14/2000WO2000053583A1 Inhibitors of protein tyrosine phosphatase
09/14/2000WO2000053581A2 Heterocyclic compounds having antitumor activity
09/14/2000WO2000053573A1 Medicinal compositions with [2.2.1] and [3.1.1] bicycloskeleton antagonistic to both of pgd2/txa2 receptors
09/14/2000WO2000053572A1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor
09/14/2000WO2000053568A1 Sphingoid base derivatives and uses thereof
09/14/2000WO2000053566A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt
09/14/2000WO2000053563A1 Novel ligands of nuclear receptors ppar's
09/14/2000WO2000053562A1 Retinoid antagonists and use thereof
09/14/2000WO2000053547A1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
09/14/2000WO2000053264A1 Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin
09/14/2000WO2000053233A1 Use of protein conformation for the protection and release of chemical compounds
09/14/2000WO2000053231A2 Fatty acid-anticancer conjugates and uses thereof
09/14/2000WO2000053228A2 Use of niaouli essential oil as transdermal permeation enhancer
09/14/2000WO2000053225A1 Analgesic compositions comprising anti-epileptic compounds and methods of using same
09/14/2000WO2000053224A2 Use of inhibitors of endotoxin for the treatment of heart failure and of cachexia
09/14/2000WO2000053218A1 Neurodegenerative disorder related gene
09/14/2000WO2000053208A2 Small molecules having glp-2 like activity
09/14/2000WO2000053204A1 A pharmaceutical composition for treating angiocardiopathy and the method of producing thereof
09/14/2000WO2000053203A1 Anti-hiv agent
09/14/2000WO2000053194A1 Remedies for joint diseases
09/14/2000WO2000053191A2 Modulation of skeletal muscle precursor cell activation
09/14/2000WO2000053190A1 Novel immunosuppressants
09/14/2000WO2000053188A1 New combination of r,r-formoterol and budesonide in a pharmaceutical composition useful for treating respiratory disorders, such as asthma, rhinitis and copd
09/14/2000WO2000053187A1 New combination of formoterol and mometasone in a pharmaceutical composition for treating respiratory disorders, such as asthma, rhinitis and copd
09/14/2000WO2000053186A1 Topical compositions containing a combination of an antifungal agent and a steroidal antiinflammatory agent
09/14/2000WO2000053185A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053184A1 Drug composition for percutaneous absorption
09/14/2000WO2000053183A1 Medicament against dysmenorrhoea and premenstrual syndrome
09/14/2000WO2000053182A2 3-cyclopropylmethoxy-4-difluoromethoxy-n-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis
09/14/2000WO2000053181A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053178A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053177A1 Liposome preparations
1 ... 6245 6246 6247 6248 6249 6250 6251 6252 6253 6254 6255 6256 6257 6258 6259 6260 6261 6262 6263 6264 6265 ... 7860